Q1 2025 Seer Inc Earnings Call Transcript
Key Points
- Seer Inc (SEER) reported a strong start to the year with $4.2 million in revenue for Q1 2025, driven by increasing demand for the Proteograph product suite.
- The company shipped as many instruments in Q1 2025 as were shipped in all of 2024, indicating strong market traction.
- Seer Inc (SEER) has a robust balance sheet with approximately $285 million in cash, cash equivalents, and investments, providing a significant advantage in the current environment.
- The company is making strategic investments in R&D and continuing its share repurchase program, reflecting confidence in its core value proposition.
- Seer Inc (SEER) has secured a significant contract for a 10,000-sample study, marking a key milestone for the proteomics market and demonstrating the scalability of its technology.
- Seer Inc (SEER) faces macroeconomic volatility, including tariffs and government funding challenges, which could impact visibility for the rest of the year.
- The company reported a net loss of $19.9 million for Q1 2025, slightly lower than the $20.7 million loss in Q1 2024.
- There is ongoing uncertainty in the NIH and government funding environment, which could impact academic and government revenue, representing about 30% of Seer Inc (SEER)'s overall revenue.
- The company anticipates potential revenue variability due to the size and timing of large-scale projects, which could affect quarterly performance.
- Seer Inc (SEER) is experiencing elongated sales cycles and pressure on CapEx budgets, impacting the outright purchase of new instruments.
Good day, and thank you for standing by. Welcome to Seer first quarter 2025 earnings conference call. At this time all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions)Please be advised that today's conference is being recorded.
I would now like to hand the conference over to Kelly Gura, Investor Relations. Please go ahead.
Thank you. So earlier today, Seer released financial results for the quarter ended March 31, 2025. If you've not received this news release or if you'd like to be added to the company's distribution list, please send an email to [email protected]. In addition, during today's conference call, we will be referencing a slide presentation that can be accessed on the Events and Presentation section of Seer's Investor Relations website.
Joining me today from Seer is Omid Farokhzad, Chief Executive Officer and Chair of the Board; and David Horn, Chief Financial Officer and President. Before we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
